Hydrogel Film Wound Dressing Testing: Standards, Test Items, and Technical Methods

Hydrogel film wound dressing testing is a critical step in verifying the safety, performance, and regulatory compliance of hydrogel-based dressings intended for the management of acute and chronic wounds. This technical article provides a comprehensive overview of the sample types, test items, and internationally recognized methods—such as ISO 10993, EN 13726, ASTM, GB/T, and YY/T standards—commonly applied by accredited third-party laboratories to evaluate hydrogel wound dressing films.

Technical Overview

Hydrogel film dressings are three-dimensional, cross-linked networks of hydrophilic polymers that typically contain 70% to 95% water by mass. Common base polymers include polyvinyl alcohol (PVA), polyethylene glycol or polyethylene oxide (PEG/PEO), polyvinylpyrrolidone (PVP), polyacrylamide, sodium polyacrylate, sodium carboxymethyl cellulose, and alginate-based blends, which may be physically or chemically cross-linked and often combined with humectants such as glycerol. When applied to a wound, these materials donate moisture to dry or low-exuding wounds, absorb moderate amounts of exudate, maintain a moist wound-healing environment, and provide a cooling and analgesic effect.

Because hydrogel dressings contact breached skin and open wound surfaces, frequently for extended durations, they are regulated as medical devices in most jurisdictions. A structured testing program is therefore required to demonstrate physical integrity, functional fluid-handling performance, chemical safety, biocompatibility, sterility, packaging integrity, and shelf-life stability. Testing is generally performed against internationally recognized frameworks, including the ISO 10993 series for biological evaluation, the EN 13726 series for primary wound dressing performance, ASTM guides for hydrogel characterization and packaging, and the corresponding GB/T 16886 and YY/T 0471 series adopted in China.

Testing Samples

Finished Sterile Products

The primary test article is the finished hydrogel film dressing in its final commercial form, final packaging, and sterilized state. Testing on the as-delivered product ensures that results reflect the influence of manufacturing, sterilization, and packaging processes on material performance.

Raw Materials and Polymer Components

Monomers, cross-linking agents, polymerization initiators, humectants, purified water, and any backing films or release liners may be individually characterized to support material qualification, supplier control, and toxicological risk assessment.

In-Process Samples

Samples taken at key manufacturing stages, such as after casting, cross-linking, or drying, are used to verify process parameters, including degree of cross-linking, gel fraction, residual monomer levels, and water content.

Stability and Shelf-Life Samples

Products in intact primary packaging are subjected to real-time and accelerated aging conditions to substantiate labeled expiry dates and to confirm that critical properties remain within specification throughout the intended shelf life.

Testing Items

Physical and Mechanical Performance

• Appearance, dimensions, thickness uniformity, and mass per unit area
• Tensile strength and elongation at break of the hydrogel film or composite laminate
• Puncture resistance and tear resistance
• Conformability, flexibility, and drape over contoured anatomical surfaces
• Cohesion and structural integrity of the gel after hydration, including resistance to dissolution or fragmentation
• Adhesive performance, such as tack and peel strength, and residue-free, atraumatic removal

Fluid Handling and Functional Properties

• Free swell absorptive capacity in standard test solutions
• Fluid handling capacity, combining absorption and evaporative loss under controlled conditions
• Moisture vapor transmission rate (MVTR) of the dressing or its backing film
• Moisture donation capacity for dry wound applications
• Total water content, swelling ratio, and gel fraction
• Waterproofness of any occlusive backing layer when liquid barrier performance is claimed

Chemical Characterization

• Chemical identity confirmation by infrared spectroscopy (FTIR)

hello

• pH of aqueous extracts
• Residual monomers, cross-linking agents, initiators, and degradation products by HPLC or GC-MS
• Elemental impurities and heavy metals by ICP-MS or ICP-OES
• Extractables and leachables profiling in accordance with ISO 10993-18
• Content uniformity of any active pharmaceutical ingredient in medicated hydrogel dressings

Biological Evaluation

• In vitro cytotoxicity in accordance with ISO 10993-5
• Sensitization in accordance with ISO 10993-10
• Skin or intracutaneous irritation in accordance with ISO 10993-23
• Additional endpoints, such as genotoxicity, hemocompatibility, subacute systemic toxicity, or implantation, when justified by contact duration and product claims under ISO 10993-1

Microbiological and Sterilization Testing

• Bioburden determination prior to sterilization in accordance with ISO 11737-1
• Sterility testing in accordance with ISO 11737-2
• Bacterial endotoxin testing where applicable
• Verification of sterilization process validation, including radiation dose substantiation per ISO 11137 or ethylene oxide residual analysis per ISO 10993-7
• Antimicrobial effectiveness testing for dressings with antimicrobial claims

Packaging and Shelf-Life Testing

• Seal strength of sterile barrier systems per ASTM F88
• Package integrity by dye penetration, internal pressurization, or vacuum decay methods
• Accelerated aging per ASTM F1980 and real-time aging studies
• Transportation and distribution simulation to confirm package robustness

Testing Methods

Absorption and fluid handling tests are typically conducted gravimetrically. Pre-weighed specimens are exposed to standardized test solutions under controlled temperature and, where specified, controlled compression, and the mass gain is recorded after defined intervals such as 30 minutes and 24 hours. Results are expressed as absorptive capacity per unit area, and combined with evaporative loss to determine total fluid handling capacity, following the principles of EN 13726-1 and YY/T 0471.1.

Moisture vapor transmission rate is measured using a permeability cup method in which the specimen seals a reservoir of liquid over a defined vapor pressure gradient, typically at 37°C, with mass loss recorded gravimetrically over 24 hours. The method follows EN 13726-2, YY/T 0471.2, or ASTM E96, and results are reported in grams per square meter per 24 hours.

Mechanical testing is performed on a universal testing machine using strip or dumbbell specimens conditioned at standard laboratory atmosphere. Tensile strength and elongation at break are determined at a constant crosshead speed in accordance with ASTM D882 or ISO 37, while puncture and tear resistance are measured with dedicated fixtures.

Cytotoxicity testing involves preparing extracts of the dressing at standardized ratios, such as 0.1 g/mL or 6 cm²/mL, in culture medium at 37°C for 24 hours, following ISO 10993-12. The extracts are then applied to L929 mouse fibroblast cultures, and cell viability is assessed using a colorimetric MTT assay; a viability of at least 70% relative to the negative control indicates the absence of cytotoxic potential under ISO 10993-5.

Residual monomer and cross-linker analysis is performed by solvent extraction followed by HPLC with UV detection or GC-MS, with acceptance limits derived from toxicological risk assessment in accordance with ISO 10993-17. Sterility testing is conducted by membrane filtration or direct inoculation into tryptic soy broth and fluid thioglycollate medium with 14 days of incubation, while ethylene oxide residuals are quantified by headspace gas chromatography when applicable.

Shelf-life studies subject packaged samples to elevated temperature and humidity conditions, and aged samples are retested against all critical quality attributes, including sterility, package integrity, absorptive capacity, adhesion, and appearance.

Applications

Hydrogel film dressing testing supports product development and regulatory submissions across major markets, including design verification and validation for technical documentation under the EU MDR, premarket notification submissions to the FDA in the United States, and registration dossiers with the NMPA in China. Manufacturers also use the resulting data for incoming material control, routine batch release, process change assessment, and post-market surveillance.

Clinically, the products covered by this testing scope are used in the management of chronic wounds such as diabetic foot ulcers, venous leg ulcers, and pressure injuries, as well as acute wounds including abrasions, donor sites, partial-thickness burns, and post-procedure or post-laser skin care. Verified fluid donation, vapor transmission, and atraumatic removal properties are particularly important for painful, dry, or granulating wounds where maintaining a moist environment without maceration of periwound skin is essential.

FAQ

What biocompatibility tests are required for hydrogel wound dressings?

For surface devices contacting breached skin or open wounds, the baseline biological evaluation typically includes cytotoxicity, sensitization, and irritation. Additional endpoints, such as genotoxicity, systemic toxicity, or implantation studies, may be required depending on contact duration, resorbable claims, and the outcome of the chemical characterization and risk assessment conducted under ISO 10993-1 and ISO 10993-18.

Do hydrogel dressings need to be supplied sterile?

Hydrogel dressings intended for use on open wounds are generally required to be sterile, with a sterility assurance level of 10⁻⁶. This requires validated sterilization, routine sterility and bioburden testing, and, for ethylene oxide sterilization, confirmation that residual levels comply with ISO 10993-7.

Which residual chemicals are typically controlled?

Common controlled residuals include unreacted acrylic acid or acrylamide monomers, cross-linking agents, polymerization initiators, catalysts, antioxidants, and ethylene oxide reaction products. Limits are established through toxicological risk assessment, and methods such as HPLC, GC-MS, and ICP-MS are used for quantification.

How is moisture vapor transmission rate relevant to performance?

MVTR determines whether a dressing maintains an optimal moist environment. A rate that is too low can cause exudate accumulation and maceration, while an excessively high rate can dry the wound bed. Testing per EN 13726-2 or ASTM E96 allows manufacturers to match the dressing to the intended exudate level and wound type.

What sample quantities are typically required for a full test program?

Sample requirements vary with the number of test items and the test methods involved. Sterility, cytotoxicity, chemical characterization, and functional performance testing generally require multiple full-size dressings per test, and additional units are needed for stability time points. Accredited third-party laboratories typically provide itemized sample lists during project planning.

How long does a complete evaluation take?

Physical and functional testing can often be completed within two to four weeks, while biological studies such as sensitization may require six to eight weeks or longer. Accelerated shelf-life studies depend on the claimed expiry date and the selected aging protocol. An integrated schedule is normally agreed upon during the test planning phase.